19-13932979-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001370095.3(PODNL1):c.1244G>A(p.Arg415Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000164 in 1,551,926 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001370095.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PODNL1 | NM_001370095.3 | c.1244G>A | p.Arg415Gln | missense_variant | 8/10 | ENST00000588872.3 | NP_001357024.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PODNL1 | ENST00000588872.3 | c.1244G>A | p.Arg415Gln | missense_variant | 8/10 | 3 | NM_001370095.3 | ENSP00000467395.2 |
Frequencies
GnomAD3 genomes AF: 0.000302 AC: 46AN: 152242Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000129 AC: 20AN: 155104Hom.: 0 AF XY: 0.0000710 AC XY: 6AN XY: 84496
GnomAD4 exome AF: 0.000149 AC: 208AN: 1399566Hom.: 0 Cov.: 31 AF XY: 0.000139 AC XY: 96AN XY: 692262
GnomAD4 genome AF: 0.000302 AC: 46AN: 152360Hom.: 0 Cov.: 33 AF XY: 0.000349 AC XY: 26AN XY: 74516
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 26, 2023 | The c.1265G>A (p.R422Q) alteration is located in exon 8 (coding exon 8) of the PODNL1 gene. This alteration results from a G to A substitution at nucleotide position 1265, causing the arginine (R) at amino acid position 422 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at